HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

YM-341619 suppresses the differentiation of spleen T cells into Th2 cells in vitro, eosinophilia, and airway hyperresponsiveness in rat allergic models.

Abstract
T helper (Th) 2 cells play a central role in the pathogenesis of allergic diseases such as allergic asthma, atopic dermatitis, and allergic rhinitis. We have found that YM-341619 hydrochloride, which suppressed IL-4-induced STAT6-dependent reporter gene expression, inhibited the differentiation of mouse spleen T cells into Th2 cells in vitro. YM-341619 suppressed the production of IL-4 and the expression of GATA-3 mRNA, a Th2 transcription factor, in T cells cultured with anti-CD3 antibody and anti-CD28 antibody in the presence of IL-4. In contrast, the production of IFN-gamma and the expression of T-bet mRNA, a Th1 transcription factor, in T cells cultured with anti-CD3 antibody in the presence of IL-12, were not effected by YM-341619. Orally administered YM-341619 (0.003-0.03 mg/kg) reduced the plasma IgE level of DNP-Ascaris-sensitized rats, but not the IgG(2a) level. YM-341619 suppressed IL-4 and IL-13 production in the splenocytes of these DNP-Ascaris-sensitized rats without augmenting IFN-gamma production. YM-341619 also dose-dependently suppressed eosinophil accumulation in the lung (0.003-3 mg/kg, p.o.) and airway hyperresponsiveness (0.3-3 mg/kg, p.o.) induced by repeated exposure to ovalbumin in ovalbumin-sensitized rats. These results suggest that YM-341619 has the ability to suppress allergen-induced Th2 responses by selectively inhibiting the differentiation of CD4(+) T cells into the Th2 subset.
AuthorsKeiko Ohga, Sadao Kuromitsu, Ryuichi Takezawa, Mako Numazaki, Jun Ishikawa, Shinya Nagashima, Yasuaki Shimizu
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 590 Issue 1-3 Pg. 409-16 (Aug 20 2008) ISSN: 0014-2999 [Print] Netherlands
PMID18590722 (Publication Type: Journal Article)
Chemical References
  • 2-((4-morpholin-4-ylphenyl)amino)-4-((2,3,6-trifluorobenzyl)amino)pyrimidine-5-carboxamide
  • GATA3 Transcription Factor
  • Morpholines
  • Pyrimidines
  • STAT6 Transcription Factor
  • Interleukin-4
  • Interferon-gamma
Topics
  • Animals
  • Asthma (drug therapy, immunology)
  • Bronchial Hyperreactivity (drug therapy)
  • Cell Differentiation (drug effects)
  • Dose-Response Relationship, Drug
  • Eosinophilia (drug therapy)
  • Female
  • GATA3 Transcription Factor (genetics)
  • Interferon-gamma (biosynthesis)
  • Interleukin-4 (antagonists & inhibitors, biosynthesis)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Morpholines (pharmacology, therapeutic use)
  • Promoter Regions, Genetic
  • Pyrimidines (pharmacology, therapeutic use)
  • Rats
  • Rats, Inbred BN
  • Rats, Wistar
  • STAT6 Transcription Factor (genetics)
  • Spleen (cytology)
  • T-Lymphocytes (cytology)
  • Th2 Cells (cytology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: